Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism
- Cancer patients are at high risk of developing blood clots
- Deep vein thrombosis (DVT) and pulmonary embolism (PE) collectively known as venous thromboembolism (VTE), can cause death and disability
- Tablet found to reduce recurrence of VTE
Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.
People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots in the deep veins of the leg may travel to the lungs causing a pulmonary embolism. These two conditions are referred to as VTE – a dangerous and potentially deadly medical condition of which there are 10 million cases worldwide.
To view the full story, please click here.
